Christopher R. Seaton

Presidente en Middlesex Hospital .

Health Services

Consumer Services

Health Technology

Perfil

Christopher R.
Seaton is currently the Chairman at Middlesex Hospital and Director at Versantis AG.
He completed his undergraduate and MBA degrees from McMaster University.

Cargos activos de Christopher R. Seaton

Empresas	Cargo	Inicio
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Presidente	19/04/2010
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Director/Miembro de la Junta	05/02/2021

Todos los cargos activos de Christopher R. Seaton

Formación de Christopher R. Seaton.

McMaster University

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher R. Seaton.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Middlesex Hospital Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family.	Health Services
Versantis AG Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.	Health Technology